Mysterious death of 5 siblings in Egypt
The body of the girl, Rahma Nasser Mohamed, was transferred to the morgue, under the disposition of the investigative authorities, in preparation for presentation to the forensic doctor and completing the necessary legal procedures to unravel the causes of death, which are still surrounded by questions.
Social media sites in Egypt have seen widespread interaction after the announcement of the death of four children from one family, including Reem Nasser (10 years), Omar Nasser (7 years), Mohamed Nasser (11 years), and Ahmed Nasser (5 years), due to severe symptomatic illness. It was reported that they were admitted to Deir Mawas Central Hospital suffering from high fever, headache, neck stiffness, as well as irritability, vomiting, and allergies.
In an official statement issued by the Egyptian Ministry of Health on Sunday, July 14, the ministry denied that the deaths were due to meningitis infection, affirming that the rumors in this regard are not based on documented information or analytical results.
The statement clarified that infectious diseases do not lead to deaths at the same time among family members, indicating that deaths resulting from family outbreaks are temporally close, but not on the same day, as in this incident.
The statement added that the body's response to infections varies according to age, immune status, and viral load, making it medically improbable for the death to occur on the same day for four children.
The Egyptian Public Prosecution is conducting extensive investigations into the incident, where it holds the bodies of the five children in preparation for presenting them to the forensic medicine, in an effort to determine the real causes of death and ascertain whether there is a criminal suspicion behind this tragic event that shook Delga village and the entire Minya province.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wamda
an hour ago
- Wamda
UAE femtech Ovasave secures $1.2 million to expand in Saudi, GCC
UAE-based femtech startup Ovasave, backed by Abu Dhabi's Hub71, has raised $1.2 million in pre-seed funding from regional and international investors. The round was led by PlusVC, Annex Investments, and 25 Madison, with participation from strategic angel investors and family offices in the UAE and Saudi Arabia. Founded in 2023 by Majd Abu Zant and Torkia Mahloul, Ovasave offers a digital-first platform for fertility and hormonal health, combining at-home hormone testing, virtual consultations, personalised supplement protocols, and egg freezing support. The company also partners with corporates to integrate fertility and hormone care into employee wellbeing benefits. The $1.2 million raise will fuel Ovasave's expansion into Saudi Arabia and across the GCC, support scaling of corporate partnerships, and fund the next phase of its mobile app. Press release: Ovasave, a Hub71 FemTech startup focused on fertility and hormonal health, has successfully completed its pre-seed round, raising $1.2 million from a mix of regional and international investors. The round was led by PlusVC, Annex Investments, and New York-based 25 Madison, with additional backing from UAE and Saudi-based strategic angel investors and prominent family offices. This reflects the strong investors' confidence and growing demand for innovation in women's health across the region. Founded in 2023, Ovasave offers women a seamless, digital-first experience for fertility testing, egg freezing, hormone management, and menopause care. The platform combines at-home hormone testing, virtual consultations, personalised supplement protocols, and access to top fertility clinics for fertility preservation (egg freezing). Positioned as disruptors in fertility and women's hormonal health, Ovasave has also established a growing corporate benefits scheme that helps organisations support employees' reproductive health as part of their workplace wellbeing programmes. The $1.2m capital raised will be used to support regional expansion across the GCC, scale corporate partnerships, and launch the next phase of Ovasave's mobile app, which will include menstrual cycle tracking, symptom monitoring, access to care, and AI-driven treatment protocols. Ovasave will also address a historically overlooked stage of women's health, offering a broader range of services targeting perimenopause and menopause. The raise comes as the UAE accelerates national reforms in healthcare and women's rights, offering a timely window for FemTech innovation. Ovasave is registered with the Department of Health – Abu Dhabi and supported by Abu Dhabi's global tech ecosystem, Hub71, further aligning it with the nation's broader digital and preventive health strategies. Majd Abu Zant, Co-founder of Ovasave and global leader in fertility and women's healthcare, said, 'Abu Dhabi's focus on innovation, healthcare, and entrepreneurship has created a competitive environment for founders and investors alike. As an Abu Dhabi-based startup supported by Hub71, Ovasave has benefited from a strong regulatory framework, access to capital, and proximity to regional decision-makers. It's the right environment to build and scale high-impact ventures, and from here, we are expanding into Saudi Arabia and the wider MENA region.' A recent report by FemTech Analytics (FTA) revealed that the FemTech market in the MENA region is projected to reach $3.8 billion by 2031, growing at a CAGR of 15% during the forecast period from 2021 to 2031. (source: FTA Study, 2021) 'Overall, FemTech in the UAE is still in its early stages, but the momentum is clear. With increasing investor interest and a strong national focus on women's health and innovation, the UAE is emerging as a regional hub for the growth of this sector,' Abu Zant added. Torkia Mahloul, Co-founder and CEO of Ovasave, said, "There is a critical need for timely intervention in women's health, particularly around fertility and hormonal health. This funding marks a crucial step in our mission to disrupt women's health and expand access to fertility and hormonal care across the region. We are grateful for the confidence shown by our investors, which allows us to scale a platform designed to deliver timely, personalised, and accessible fertility and hormonal care. By bringing together medical expertise, digital convenience, and emotional support, we are helping women take control of their health earlier and more effectively across different life stages.' Built with a clear purpose, Ovasave is shifting women's care from reactive to proactive. Its solutions are designed to reduce costs, improve outcomes, and make it easier for women to access support in an area that has long been considered taboo and under-discussed. Moreover, Ovasave has embedded public education into its core mission, organising awareness events and expert talks and collaborating with physicians to normalise fertility conversations. One of its standout initiatives was the 'Fertility Your Way' campaign with Merck Gulf, offering free AMH screenings across the UAE. More than 500 women were screened during the campaign. The startup also partnered with leading employers including Aldar, Boston Consulting Group, and WeWork to raise awareness of fertility in the workplace. Through these efforts, Ovasave is helping shift the narrative on reproductive health across the region. "With investor confidence and strong market demand, the conversation around women's health is changing, signalling that fertility and hormonal care are no longer peripheral issues. Women's health is now a priority for innovation and investment in the Middle East, and we are proud to be leading that change,' Mahloul concluded. Ovasave's fundraising comes amid growing investor interest in women's health and fertility innovation across the MENA region. With a $1.2M pre-seed round now closed, Ovasave is expanding operations to Saudi Arabia this summer, with broader regional growth across MENA being part of their 3-year expansion strategy.
Ammon
2 hours ago
- Ammon
WHO thanks Jordan, urges countries to receive patients from Gaza
Ammon News - The World Health Organization (WHO) called on more countries to receive and treat patients from the Gaza Strip, following the medical evacuation of a group of patients, most of them children, to Jordan. WHO Director-General, Tedros Adhanom Ghebreyesus, said Wednesday in a post on his official X account: "Today, WHO led the medical evacuation of 35 patients, mostly children, from Gaza to Jordan, accompanied by 72 family members." "We are grateful to the government of Jordan for its continued support and for providing specialized care to critically ill patients," Ghebreyesus added. Additionally, he stated: "More than 10,000 people in Gaza still need medical evacuation. We urge more countries to step forward to accept patients for medical evacuations - lives depend on it. There are many more waiting." Today, @WHO led the medical evacuation of 35 patients, mostly children, from #Gaza to #Jordan, accompanied by 72 family members. We are grateful to the government of 🇯🇴 for its continued support and for providing specialized care to critically ill patients. More than 10,000… — Tedros Adhanom Ghebreyesus (@DrTedros) July 16, 2025
Roya News
12 hours ago
- Roya News
Bodies of security forces and civilians found in Sweida hospital
Syria's Health Ministry announced the discovery of dozens of bodies inside Sweida hospital following the withdrawal of armed groups from the area. According to state media SANA, the victims include members of the Syrian security forces and civilians.
